查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1683379

全球復健機器人外骨骼市場 - 2025 至 2033 年

Global Robotic Exoskeletons for Rehabilitation Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球復健機器人外骨骼市場規模達 4.28 億美元，預計到 2033 年將達到 12.37 億美元，2025-2033 年預測期內的複合年成長率為 12.5%。

復健用機器人外骨骼是一種穿戴式設備，可幫助患有行動不便問題的人，例如脊髓損傷、中風或神經系統疾病引起的行動不便的人。這些設備具有輕質的框架，可圍繞使用者的身體，並包含馬達、感測器和執行器以協助運動，尤其是步行。它們支撐使用者的身體，使患者能夠參與復健鍛煉，提高行走能力並在日常生活中獲得獨立性。

市場動態：

促進因素與約束因素

肌肉骨骼疾病盛行率不斷上升

肌肉骨骼疾病的盛行率不斷上升，預計將大大推動機器人外骨骼在復健市場的發展。肌肉骨骼疾病，包括脊髓損傷、中風和神經系統疾病，通常會導致行動能力受損，因此復原對於復原至關重要。患有肌肉骨骼疾病的人數正在增加。

例如，根據美國國立衛生研究院 2023 年的報告，約有 17.1 億人患有肌肉骨骼疾病。隨著全球人口老化和這些疾病的發生率上升，對機器人外骨骼等先進復健解決方案的需求也隨之增加。

個人化復健治療的需求日益成長，以及對更有效的恢復選擇的渴望進一步推動了機器人外骨骼的採用。隨著越來越多的患者尋求肌肉骨骼損傷的創新解決方案，機器人外骨骼提供了恢復功能和獨立性的有效方法，推動了市場的成長。

嚴格的監管框架

機器人外骨骼的高成本可能會嚴重限制這些設備復健市場的成長。這些外骨骼採用了先進的技術、專門的材料和複雜的工程，所有這些都增加了生產和購買成本。此外，維護設備和培訓醫療保健提供者使用這些設備的費用可能會成為許多醫院和復健中心的障礙，特別是在醫療保健預算有限的地區。因此，機器人外骨骼的高昂價格可能會阻礙其廣泛採用和使用。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按類型分類的程式碼片段
  • 按患者類型分類
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 肌肉骨骼疾病盛行率不斷上升
      • 不斷進步的技術
    • 限制
      • 機器人外骨骼成本高昂
      • 缺乏意識
    • 機會
      • 擴充應用
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 5 章：復健機器人外骨骼市場（按類型）

  • 下肢外骨骼
  • 上身外骨骼
  • 全身外骨骼

第 6 章：復健市場機器人外骨骼（依患者類型）

  • 已停用
  • 兒科
  • 老年

第 7 章：復健機器人外骨骼市場（按應用）

  • 神經復健
  • 脊髓損傷康復
  • 骨科復健
  • 其他

第 8 章：復健機器人外骨骼市場（依最終用戶分類）

  • 復健中心
  • 醫院和診所
  • 孤兒院
  • 居家護理

第 9 章：復健機器人外骨骼市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • Cyberdyne Care Robotics GmbH
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • BIONIK
  • ExoAtlet
  • Lifeward, Inc.
  • Gogoa.eu
  • German Bionic Systems GmbH
  • Siyi Intelligent Technology Co., Ltd.
  • Hocoma
  • Rex Bionics Ltd.
  • RoboCT

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD9319

The global robotic exoskeletons for rehabilitation market reached US$ 428 million in 2024 and is expected to reach US$ 1,237 million by 2033, growing at a CAGR of 12.5% during the forecast period 2025-2033.

Robotic exoskeletons for rehabilitation are wearable devices that help people with mobility issues, like those caused by spinal cord injuries, stroke, or neurological conditions. These devices have a lightweight frame that fits around the user's body and includes motors, sensors, and actuators to assist with movement, especially walking. They support the user's body, allowing patients to participate in rehabilitation exercises, improve their walking ability, and gain independence in their daily lives.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Musculoskeletal Disorders

The increasing prevalence of musculoskeletal disorders is expected to significantly drive the robotic exoskeletons for the rehabilitation market. Musculoskeletal conditions, including spinal cord injuries, stroke, and neurological disorders, often result in impaired mobility, making rehabilitation essential for recovery. There is a growing number of individuals suffering from musculoskeletal disorders.

For instance, according to the National Institute of Health in 2023, it is reported that approximately 1.71 billion people are living with a musculoskeletal condition. As the global population ages and the incidence of these disorders rises, the demand for advanced rehabilitation solutions like robotic exoskeletons increases.

The growing need for personalized rehabilitation treatments and the desire for more effective recovery options further boost the adoption of robotic exoskeletons. As more patients seek innovative solutions for musculoskeletal impairments, robotic exoskeletons provide an effective way to restore functionality and independence, driving growth in the market.

Stringent Regulatory Frameworks

The high costs of robotic exoskeletons could significantly limit the growth of the rehabilitation market for these devices. These exoskeletons are made with advanced technology, specialized materials, and intricate engineering, all of which drive up the production and purchase costs. Additionally, the expenses associated with maintaining the devices and training healthcare providers to use them can be barriers for many hospitals and rehabilitation centers, particularly in areas with constrained healthcare budgets. As a result, the steep price of robotic exoskeletons could prevent widespread adoption and use.

Segment Analysis

The global robotic exoskeletons for rehabilitation market is segmented based on the type, patient type, application, end-user and region.

Lower body exoskeletons in the type segment is expected to dominate the robotic exoskeletons for rehabilitation market

The lower body exoskeletons segment is expected to dominate the robotic exoskeletons for the rehabilitation market due to their significant ability to restore mobility and independence for individuals with lower limb impairments. A large number of individuals suffer and experience lower limbs, hip, and knee fractures, which require rehabilitation after a certain period.

For instance, according to a study by the National Institute of Health in 2024, the overall incidence of lower limb fractures was 215.9 lower limb long bone fractures per 100,000 patients per year. These devices, which help patients with conditions like spinal cord injuries, stroke, and neurological disorders regain the ability to walk and perform functional movements, are increasingly seen as essential for rehabilitation.

The growing focus on active rehabilitation over passive treatments is driving adoption, as lower body exoskeletons enable patients to engage in weight-bearing activities such as walking, standing, and even climbing stairs. These activities are vital for improving muscle strength, bone density, and overall recovery.

Additionally, continuous advancements in technology have made these devices more user-friendly, cost-effective, and efficient, further expanding their reach in healthcare settings. As a result, the segment is expected to dominate the market, driven by rising patient demand, clinical benefits, and ongoing technological innovations.

Geographical Analysis

North America is expected to dominate the robotic exoskeletons for rehabilitation market

North America is expected to maintain a dominant position in the robotic exoskeletons for the rehabilitation market, driven by several key factors. The region's advanced healthcare infrastructure plays a crucial role in facilitating the adoption of innovative technologies, such as robotic exoskeletons, particularly in the United States. The country dominates in both the development and implementation of these devices, supported by significant contributions from major companies and research institutions advancing robotic rehabilitation solutions.

Additionally, North America benefits from substantial healthcare expenditure, enabling hospitals and rehabilitation centers to invest in advanced equipment. Well-established health insurance systems that can cover the costs of medical devices, coupled with an increasing focus on rehabilitation therapies for patients with spinal cord injuries, strokes, and other mobility challenges, further support market growth.

Companies in the region are entering into strategic collaborations to expand and innovate advanced robotic exoskeletons for rehabilitation.

For instance, in May 2024, DIH Holding US, Inc. entered a strategic collaboration with B-Temia Inc. to drive AI-based innovation and smart solutions in the rehabilitation industry. This partnership combines B-Temia's expertise in AI-driven robotics with DIH's broad robotic portfolio, marking a significant step in improving functional rehabilitation and support in North America. Thus, the above factors are combinedly driving the region's growth and holding the region in a dominant position.

Competitive Landscape

The global market players in the robotic exoskeletons for rehabilitation market are Cyberdyne Care Robotics GmbH, BIONIK, ExoAtlet, Lifeward, Inc., Gogoa.eu, German Bionic Systems GmbH, Siyi Intelligent Technology Co., Ltd., Hocoma, Rex Bionics Ltd., and RoboCT, among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global robotic exoskeletons for rehabilitation market report would provide approximately 45 tables, 46 figures and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Patient Type
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Prevalence of Musculoskeletal Disorders
      • 3.1.1.2. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs Associated with the Robotic Exoskeletons
      • 3.1.2.2. Lack of Awareness
    • 3.1.3. Opportunity
      • 3.1.3.1. Expanding Applications
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Robotic Exoskeletons for Rehabilitation Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Lower Body Exoskeletons*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Upper Body Exoskeletons
  • 5.4. Full Body Exoskeletons

6. Robotic Exoskeletons for Rehabilitation Market, By Patient Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 6.1.2. Market Attractiveness Index, By Patient Type
  • 6.2. Disabled*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Pediatrics
  • 6.4. Elderly

7. Robotic Exoskeletons for Rehabilitation Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Neuro Rehabilitation*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Spinal Cord Injury Rehabilitation
  • 7.4. Orthopedic Rehabilitation
  • 7.5. Others

8. Robotic Exoskeletons for Rehabilitation Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Rehabilitation Centers*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hospitals & Clinics
  • 8.4. Orphanages
  • 8.5. Homecare

9. Robotic Exoskeletons for Rehabilitation Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Cyberdyne Care Robotics GmbH*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. BIONIK
  • 11.3. ExoAtlet
  • 11.4. Lifeward, Inc.
  • 11.5. Gogoa.eu
  • 11.6. German Bionic Systems GmbH
  • 11.7. Siyi Intelligent Technology Co., Ltd.
  • 11.8. Hocoma
  • 11.9. Rex Bionics Ltd.
  • 11.10. RoboCT

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us